Your session is about to expire
← Back to Search
Intrauterine Device
Mona Lisa® NT Cu380 Mini for Birth Control
Phase 3
Waitlist Available
Research Sponsored by Kimberly Myer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
This trial tests two types of copper IUDs in women eligible for IUD use to compare their effectiveness and safety. Copper IUDs work by releasing copper ions that prevent sperm from fertilizing an egg. The TCu 380A (Paragard) is a widely used copper IUD known for its safety and effectiveness.
Eligible Conditions
- Healthy Women
- Birth Control
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mona Lisa® NT Cu380 MiniExperimental Treatment1 Intervention
Mona Lisa® NT Cu380 Mini containing 380mm2 of copper surface inserted into the uterine cavity.
Group II: ParaGard® CuT380AActive Control1 Intervention
ParaGard® CuT380A containing 380mm2 of copper surface inserted into the uterine cavity.
Find a Location
Who is running the clinical trial?
Kimberly MyerLead Sponsor
FHI 360OTHER
100 Previous Clinical Trials
300,377 Total Patients Enrolled
Health DecisionsLead Sponsor
30 Previous Clinical Trials
12,897 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger